Weightwatchers
Sort by
5 items
-
Inc. - Business
WeightWatchers CEO to Step Down After 2 Years
The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and Wegovy.3 hours ago -
Financial Times - Business
General Atlantic nears £800mn deal to buy UK’s Learning Technologies
London-based group is ‘minded to recommend’ the 100p per share offer from private equity group7 hours ago -
Financial Times - Business
WeightWatchers chief quits as company struggles against anti-obesity drugs
Sima Sistani leaves despite effort to transform group into online prescriber7 hours ago -
Financial Times - Business
Everyone’s on Ozempic. So why will no one talk about it?
The fashion world is embracing weight-loss drugs — discreetly10 hours ago